• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Only low risk of HIV transmission among those well controlled on antiretroviral therapy

byMichael Milligan
July 13, 2016
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. This prospective study found no instances of HIV transmission among serodiscordant couples engaging in condomless sexual intercourse when the HIV-infected partner was taking antiretroviral therapy and maintaining a viral load below 200 copies/mL.

2. The calculated upper limit of HIV transmission risk in these couples is 0.3 per 100 couple-years overall, and 0.71 per 100 couple-years for anal intercourse.

Evidence Rating Level: 2 (Good)

Study Rundown: It has been long established that HIV-infection can be spread primarily by sexual contact, among other routes. Previous studies have shown that the use of antiretroviral therapy (ART) can reduce the rate of transmission by as much as 96%. Therefore, the World Health Organization has recommended the widespread use of ART in all HIV-infected patients, regardless of CD4 count, in an effort to stem the spread of disease. However, much of the data used to support this guideline have come from studies in which couples have reported diligent condom use. Thus, to determine the effectiveness of this recommendation in a broader population, the Partners of People on ART – A New Evaluation of the Risks (PARTNER) study sought to determine the rate of transmission in couples reporting condomless intercourse. This study followed a large number of serodiscordant couples that engaged in condomless sex in which the HIV-infected partner was taking ART and maintained a viral load below 200 copies/mL. It found a transmission rate of 0% for all forms of sex. The upper confidence limit of transmission was calculated to be 0.3/100 couple-years overall, and 0.71/100 couple-years for anal penetrative sex.

This study shows that the rate of HIV transmission is low among serodiscordant couples in which the HIV-infected partner is well controlled on ART. However, it was not designed to estimate the risk of transmission at different points of infection and was conducted with only a minimal duration of follow-up. Thus, longer-term studies are needed to provide more precise temporal estimates of risk.

Click to read the study in JAMA

RELATED REPORTS

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

Safety of investigational vaccines against human immunodeficiency virus

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

Relevant Reading: Viral load and heterosexual transmission of Human Immunodeficiency Virus type 1

In-Depth [prospective cohort]: The PARTNER trial observed a total of 1166 HIV serodiscordant couples from 14 different countries who reported condomless sexual intercourse between September 2010 and May 2014. Couples were eligible for enrollment as long as the HIV-infected partner was taking suppressive ART and their HIV-1 RNA load remained less than 200 copies/mL. A total of 888 couples (548 heterosexual, 340 MSM) reported information over a mean follow-up of 1.3 years. Couples that contributed data tended to be older, engage in longer durations of condomless sex, and have higher CD4 counts on average. During follow-up couples engaged in condomless sex 37 times per year on average. By the end of the study period, 11 total HIV-negative partners became infected (10 MSM, 1 heterosexual, 8 reported condomless sex with partners outside of their studied relationship), however, no transmission of phylogenetically linked virus occurred. Thus, the overall rate of within-couple HIV transmission was reported as 0 (transmission rate 95% CI 0 to 0.3/100 couple-years of follow-up). The transmission rate for anal intercourse was also 0 with a 95% upper-limit of approximately 0.71/100 couple-years of follow up.

 

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antiretroviralhuman immunodeficiency virus (HIV)
Previous Post

Common surgical procedures linked with increased risk of chronic opioid use

Next Post

The REMATCH trial: Left ventricular assist devices reduce mortality in heart failure [Classics Series]

RelatedReports

Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

June 16, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons
StudyGraphics

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

December 11, 2024
Kidney Transplantation from Donors with Human Immunodeficiency Virus (HIV) is  Non-inferior to Donors Without HIV
StudyGraphics

Kidney Transplantation from Donors with Human Immunodeficiency Virus (HIV) is Non-inferior to Donors Without HIV

October 24, 2024
Next Post
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The REMATCH trial: Left ventricular assist devices reduce mortality in heart failure [Classics Series]

President Obama reflects on the Affordable Care Act

President Obama reflects on the Affordable Care Act

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Catheter ablation more effective than antiarrythmic escalation for ventricular tachycardia: The VANISH trial

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline
  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]
  • The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.